Publications

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers. Cabel, L.; Fuerea, A.; Lacroix, L.; Baldini, C.; Martin, P.; Hollebecque, A.; Postel-Vinay, S.; Varga, A.; Balheda, R.; Gazzah, A.; Michot, J. M.; Marabelle, A.; Rouleau, E.; Solary, E.; De Baere, T.; Angevin, E.; Armand, J. P.; Michiels, S.; Scoazec, J. Y.; Ammari, S.; André, F.; Soria, J. C.; Massard, C.; Verlingue, L.. Oncotarget. 2018; 9741-9750: p.9741-9750. doi:10.18632/oncotarget.24188
Article
[Dermatological features of auto-inflammatory recurrent fevers]. Escudier, A.; Mauvais, F.-X.; Bastard, P.; Boussard, C.; Jaoui, A.; Koskas, V.; Lecoq, E.; Michel, A.; Orcel, M.-C.; Truelle, P.-E.; Wohrer, D.; Piram, M.. Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie. 2018; 25: p.150-162. doi:10.1016/j.arcped.2017.12.001
Article
Back-to-back comparison of penKID with NephroCheck® to predict acute kidney injury at admission in intensive care unit: a brief report. Gayat, Etienne; Touchard, Cyril; Hollinger, Alexa; Vieillard-Baron, Antoine; Mebazaa, Alexandre; Legrand, Matthieu; FROG ICU study investigators. Critical Care (London, England). 2018; 22: p.24. doi:10.1186/s13054-018-1945-9
Article
Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS). Boyer, Olivier; Bridoux, Valérie; Giverne, Camille; Bisson, Aurélie; Koning, Edith; Leroi, Anne-Marie; Chambon, Pascal; Déhayes, Justine; Le Corre, Stephanie; Jacquot, Serge; Bastit, Dominique; Martinet, Jérémie; Houivet, Estelle; Tuech, Jean-Jacques; Benichou, Jacques; Michot, Francis; and the Study Group of Myoblast Therapy for Faecal Incontinence. Annals of Surgery. 2018; 267: p.443-450. doi:10.1097/SLA.0000000000002268
Article
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma. Grill, J.; Massimino, M.; Bouffet, E.; Azizi, A. A.; McCowage, G.; Canete, A.; Saran, F.; Le Deley, M. C.; Varlet, P.; Morgan, P. S.; Jaspan, T.; Jones, C.; Giangaspero, F.; Smith, H.; Garcia, J.; Elze, M. C.; Rousseau, R. F.; Abrey, L.; Hargrave, D.; Vassal, G.. J Clin Oncol. 2018; 951-958: p.951-958. doi:10.1200/JCO.2017.76.0611
Article
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy. Ou, D.; Garberis, I.; Adam, J.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J. Y.; Deutsch, E.; Tao, Y.. Radiother Oncol. 2018; 116-124: p.116-124. doi:10.1016/j.radonc.2017.10.007
Article
Les biais de genre en épidémiologie : les cancers professionnels féminins. Bentansedi, Charles-Olivier. []: Université Paris-Sud et EHESP; 2018.
    Thesis
    Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level. van den Brink, W.; Addolorato, G.; Aubin, H. J.; Benyamina, A.; Caputo, F.; Dematteis, M.; Gual, A.; Lesch, O. M.; Mann, K.; Maremmani, I.; Nutt, D.; Paille, F.; Perney, P.; Rehm, J.; Reynaud, M.; Simon, N.; Söderpalm, B.; Sommer, W. H.; Walter, H.; Spanagel, R.. Addict Biol. 2018; 969-986: p.969-986. doi:10.1111/adb.12645
      Article
      Jointly Modelling Single Nucleotide Polymorphisms With Longitudinal and Time-to-Event Trait: An Application to Type 2 Diabetes and Fasting Plasma Glucose. Canouil, Mickaël; Balkau, Beverley; Roussel, Ronan; Froguel, Philippe; Rocheleau, Ghislain. Frontiers in Genetics. 2018; 9: p.210. doi:10.3389/fgene.2018.00210
      Article
      Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study. Hulman, Adam; Witte, Daniel R.; Vistisen, Dorte; Balkau, Beverley; Dekker, Jacqueline M.; Herder, Christian; Hatunic, Mensud; Konrad, Thomas; Færch, Kristine; Manco, Melania. Diabetes Care. 2018; 41: p.1740-1748. doi:10.2337/dc18-0279
      Article